Search clinical trials for: Type 2 diabetic kidney stone formers

Total 308 results

University Hospital, Akershus
Oslo University Hospital; AstraZeneca

Withdrawn

Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy (DECAMERONE)

Depression

Norway
Ottawa Heart Institute Research Corporation
Ontario HIV Treatment Network

Completed

The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

Human Immunodeficiency Virus (HIV) | Cardiovascular Disease (CVD)

Canada
Oslo University Hospital

Completed

Women With Chest Pain and no Significant Coronary Artery Stenosis; A Study on Microvascular Resistance

Angina Pectoris

Norway
Clinique Ovo
Merck Sharp & Dohme LLC

Terminated

NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles

Infertility

Canada
University of Hawaii

Terminated

Effect of Rosuvastatin on Endothelial Function

HIV Infections | Cardiovascular Disease

United States
AstraZeneca
Ottawa Heart Institute Research Corporation

Completed

Effects of Rosuvastatin on Aortic Stenosis Progression (ASTRONOMER)

Aortic Stenosis

Canada
Takeda

Recruiting

A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty

Central Precocious Puberty

China
National Cheng-Kung University Hospital

Completed

Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula

Diabetes Mellitus | Arteriovenous Fistula | End-stage Kidney Disease

Taiwan
Peking University Third Hospital

Unknown

Peking and Rotterdam on Mission to Reduce Coronary Artery Disease (PROMISS)

Diabetes Mellitus | Acute Coronary Syndrome

China
Universidad Autonoma de San Luis Potosí

Unknown

Effect of Rosuvastatin in Abdominal Sepsis

Sepsis

Mexico
Universidad Autonoma de San Luis Potosí

Completed

Effect of Rosuvastatin in Intracerebral Hemorrhage

Stroke | Intracerebral Hemorrhage

Mexico
AstraZeneca

Completed

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS) (HEROS)

Diabetes | Hypercholesterolemia | Coronary Heart Disease | Peripheral Vascular Disease | Cerebrovascular Accident
Loxo Oncology, Inc.
Eli Lilly and Company

Completed

A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastatin in Healthy Participants

Healthy

United States
Minneapolis Heart Institute Foundation

Active, not recruiting

The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial (DESIFOR)

Cardiovascular Diseases | Cardiovascular Risk Factor | Adverse Effect

United States
AstraZeneca

Completed

A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis

Atherosclerosis

China
Poxel SA

Completed

Safety, Tolerability and PK of PXL770 in Healthy Male Subjects

Metabolic Disease

United Kingdom
University of Vermont

Completed

Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) (DISOLVE)

Neoplasms | Deep Vein Thrombosis | Venous Thromboembolism

United States
AstraZeneca

Completed

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia (HYDRA)

Homozygous Familial Hypercholesterolemia (HoFH)

Malaysia, Canada, Israel, Netherlands, Taiwan, Belgium, Denmark
University of Rome Tor Vergata

Completed

Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients

Type 2 Diabetes | Diabetic Dyslipidemia

Italy
AstraZeneca

Completed

Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

Acute Coronary Syndrome

France, Italy, Spain, Estonia, Hungary, Canada, Belgium, Portugal, Greece, Ireland, Tunisia
Hoffmann-La Roche

Completed

A Study of RO4917838 With Rosuvastatin in Healthy Volunteers

Healthy Volunteer

France
Government Dental College and Research Institute...

Completed

Efficacy of Locally Delivred 1.2% Rosuvastatin Gel in Chronic Periodontitis

Chronic Periodontitis
Canadian Critical Care Trials Group
Canadian Institutes of Health Research (CIHR); The Physicians' Services Incorporated... and other collaborators

Terminated

Collaborative H1N1 Adjuvant Treatment Pilot Trial (CHAT)

Critically Ill | H1N1/Influenza Infection

Canada
Universidad Autonoma de San Luis Potosí
AstraZeneca; Hospital Central "Dr. Ignacio Morones Prieto"

Completed

Effect of Rosuvastatin on Amnesia and Orientation Through Galveston Outcome Amnesia Test in Moderate Head Injury

Head Injury

Mexico
AstraZeneca

Completed

Effects of Crestor on Inflammation of Atherosclerotic Plaques

Atherosclerosis | Inflammatory Activity in Carotid Arteries

Sweden
Brigham and Women's Hospital

Completed

Rho Kinase in Patients With Atherosclerosis

Atherosclerosis

United States
Hikma Pharmaceuticals LLC

Completed

Efficacy and Safety of a Generic Rosuvastatin in a Real-world Setting

Primary Hypercholesterolemia
Imperial College London

Completed

A Trial of Rosuvastatin in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus | Atherosclerosis

United Kingdom
AstraZeneca

Completed

PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.

Hypercholesterolaemia
Nanjing First Hospital, Nanjing Medical University

Recruiting

Fucoidan Assisted Eradication of Helicobacter Pylori

Helicobacter Pylori Infection | Intestinal Bacteria Flora Disturbance

China
Bayer

Completed

Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate

Healthy Volunteers | Pharmacokinetics | Drug Interaction

Germany
Shanghai Zhongshan Hospital

Unknown

Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome(NSTE-ACS)

Non-ST-elevation Acute Coronary Syndromes

China
AstraZeneca

Withdrawn

Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis (Du Lac)

Venous Thrombosis | Pulmonary Embolism
Vyriad, Inc.

Completed

Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors

Malignant Solid Tumour

United States
National Cancer Institute, Egypt

Completed

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

Prostate Cancer Metastatic

Egypt
Radboud University Medical Center
AstraZeneca; Abbott

Completed

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

HIV Infections | Hyperlipidemia

Germany, Netherlands
Gachon University Gil Medical Center

Completed

Vascular and Metabolic Effects of Rosuvastatin

Hypercholesterolemia

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Unknown

The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients

Hypercholesterolemia

Korea, Republic of
AstraZeneca

Completed

Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib (Statin DDI)

Rheumatoid Arthritis

United States
AstraZeneca

Completed

ROMEO (Rosuvastatin in Metabolic syndrOme)

Metabolic Syndrome X

Korea, Republic of
Boryung Pharmaceutical Co., Ltd
Kyungpook National University Hospital

Completed

to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin

Hypertension

Korea, Republic of
AstraZeneca
The Cleveland Clinic

Completed

CRESTOR Athero Imaging Head to Head IVUS Study (SATURN)

Coronary Atherosclerosis

United States, France, Italy, Mexico, Russian Federation, Poland, Netherlands, Canada, Argentina, Australia, Belgium, Hungary, Spain, Brazil
AstraZeneca

Completed

PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin

Familial Hypercholesterolemia

United States, Spain, Netherlands, Norway, Canada
AstraZeneca

Completed

Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP) (STARSHIP)

Hypercholesterolemia | Dyslipidaemia
Fudan University
Peking University People's Hospital; Jiangsu Wanbang Medicine Marketing Co....

Unknown

Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia

Dyslipidemias

China
AstraZeneca

Completed

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg

Healthy

United States
AstraZeneca

Withdrawn

ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals

Primary Hypercholesterolaemia
AstraZeneca

Completed

Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) (ARIES)

Hypercholesterolemia | Dyslipidaemia
AstraZeneca

Completed

COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects

Metabolic Syndrome
AstraZeneca
Mexican National Institute of Public Health

Completed

C-Reactive Protein (CRP) in Obese Diabetic Women

Diabetes Mellitus, Type 2

Mexico

Search clinical trials for: Type 2 diabetic kidney stone formers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations